DuPont’s new manufacturing site will expand its biopharmaceutical tubing manufacturing capabilities.
DuPont celebrated the opening of its DuPont Liveo Healthcare Solutions manufacturing facility on July 28, 2022. The new facility, located near Moncks Corner, SC, will expand the company’s capacity for biopharmaceutical tubing extrusion.
“The [site] will bring additional production capacity online over the next two years to serve strategic customers and expand our Liveo Healthcare Solutions customer base,” said Eugenio Toccalino, global business director, healthcare and specialty lubricants, DuPont, in a company press release. “We’re committed to investing in our healthcare business, and this biopharma processing manufacturing investment is a key milestone in our growth strategy that will help us offer a highly reliable and sustainable product supply.”
In addition to this expansion, the company also expects to add biopharma silicone tubing capacity in China in the second half of 2022.
Source: DuPont
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.